Skip to main content

Sign In |
Support |
Select your language

Menu

Products
Applications
Resources
About Us
Contact Us

Home
Resources
Publication
Patient specific Long QT syndrome type 3 cardiomyocytes can be used for clinical drug safety assessments

Patient specific Long QT syndrome type 3 cardiomyocytes can be used for clinical drug safety assessments

Bohlen B, and Brugada P.

Arrhythm Electrophysiol Rev., 2019

Related Resources

There are currently no related resources.

Related Products

System

Maestro Pro

High-throughput MEA and live-cell analysis system

Image

Axion BioSystems Maestro Pro MEA system

System

Maestro Edge

MEA and live-cell analysis system

Image

Axion BioSystems Maestro Edge system for MEA assays

Software

Cardiac Module

Record the four key measures of cardiac performance: action potential, field potential, propagation, and contractility

Image

Axion BioSystems Cardiac software Module for MEA experiments

At Axion BioSystems, our goal is to help you capture the complex biology of your cells. Whether monitoring the kinetics of cellular growth and death or recording the activity of excitable cells; Axion BioSystems' live-cell assay technology can help you record it noninvasively, in real time, and with software tools to make analysis quick and painless.

All products and application data are for research use only and not intended for human diagnostic or therapeutic uses

Useful Links

Products
Applications
Case Studies
Compliance
Travel Award

Research Areas

Cardiology
Cellular Kinetics
Neurology
Oncology
Virology

Contact Us

Contact
Inquiries
Newsletter
Office Locations
Tech Support
Request Quote
Search

© 2026 Copyright Axion BioSystems, Inc, All Rights Reserved.

Products
Applications
Resources
About Us
Contact Us
Search